ARDELYX, INC. Income Statement
ARDX / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
ARDELYX, INC. reported $407M in revenue and $62M in net loss for FY2025. Revenue has grown at a 39.4% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $407.3M | $333.6M | $124.5M | $52.2M | $10.1M | $7.6M | $5.3M | $30.0K | $24.0M | $31.6M | $24.0M | $5.4M | $28.9M | $5.4M |
| Cost of Revenue | $39.5M | $50.6M | $17.8M | $4.1M | $1.0M | $145.0K | $600.0K | $466.0K | $8.4M | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | $4.7M | $2.1M | $24.0M | - | $24.0M | - | - | - |
| SG&A Expense | $337.2M | $258.7M | $134.4M | $76.6M | $72.3M | $33.2M | $24.3M | $23.7M | $13.5M | $7.3M | $13.5M | $4.0M | $3.7M | $4.0M |
| R&D Expense | $71.5M | $52.3M | $35.5M | $35.2M | $91.1M | $65.1M | $71.7M | $69.4M | $39.9M | $25.9M | $39.9M | $10.2M | $28.1M | $10.2M |
| Operating Income | -$41.0M | -$27.9M | -$63.3M | -$63.8M | -$154.3M | -$90.8M | -$91.3M | -$90.9M | -$29.4M | -$1.6M | -$29.4M | -$8.8M | -$2.9M | -$8.8M |
| Interest Expense | - | - | $5.0M | $3.4M | $4.5M | $5.1M | $5.7M | $3.5M | - | - | - | - | - | - |
| Income Tax | $969.0K | $266.0K | $547.0K | $8.0K | $4.0K | $2.0K | $303.0K | $4.0K | -$29.0K | $67.0K | -$29.0K | $141.0K | $141.0K | - |
| Net Income | -$61.6M | -$39.1M | -$66.1M | -$67.2M | -$158.2M | -$94.3M | -$94.9M | -$91.3M | -$29.6M | -$3.2M | -$29.6M | -$9.8M | -$6.6M | -$9.8M |
| EPS (Basic) | -$0.26 | -$0.17 | -$0.30 | -$1.05 | -$1.47 | - | - | - | -$0.59 | - | -$0.19 | -$2.44 | - | - |
| EPS (Diluted) | -$0.26 | -$0.17 | -$0.30 | -$1.05 | -$1.47 | -$1.62 | -$1.36 | -$2.80 | -$0.59 | -$0.31 | -$0.19 | -$2.44 | - | -$11.32 |
| Shares Outstanding | 244.4M | 238.0M | 232.5M | 130.2M | 93.6M | 88.8M | 62.5M | 47.5M | 47.3M | 26.0M | 18.6M | 1.2M | 1.1M | 864.0K |
| Gross Margin | - | - | - | - | - | - | 88.6% | 7136.7% | 100.0% | - | 100.0% | - | - | - |
| Operating Margin | -10.1% | -8.4% | -50.8% | -122.2% | -1528.6% | -1199.1% | -1728.1% | -303156.7% | -122.3% | -5.0% | -122.3% | -162.8% | -9.9% | -162.8% |
| Profit Margin | -15.1% | -11.7% | -53.1% | -128.8% | -1566.5% | -1245.7% | -1797.8% | -304326.7% | -123.3% | -10.2% | -123.3% | -180.9% | -22.7% | -180.9% |